Bank Julius Baer & Co. Ltd Zurich Decreases Stock Holdings in Shockwave Medical, Inc. (NASDAQ:SWAV)

Bank Julius Baer & Co. Ltd Zurich decreased its stake in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) by 2.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,899 shares of the company’s stock after selling 78 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in Shockwave Medical were worth $743,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of SWAV. Lindbrook Capital LLC boosted its stake in shares of Shockwave Medical by 64.8% during the 3rd quarter. Lindbrook Capital LLC now owns 150 shares of the company’s stock valued at $30,000 after purchasing an additional 59 shares in the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Shockwave Medical by 297.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock valued at $31,000 after purchasing an additional 116 shares in the last quarter. Asset Management One Co. Ltd. bought a new stake in shares of Shockwave Medical during the 4th quarter valued at about $34,000. Operose Advisors LLC bought a new stake in Shockwave Medical during the third quarter worth about $49,000. Finally, Venturi Wealth Management LLC bought a new stake in Shockwave Medical during the third quarter worth about $82,000. Institutional investors own 95.35% of the company’s stock.

Insider Activity

In other news, VP Trinh Phung sold 1,287 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $232.18, for a total transaction of $298,815.66. Following the completion of the transaction, the vice president now directly owns 32,933 shares of the company’s stock, valued at $7,646,383.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, VP Trinh Phung sold 1,287 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $232.18, for a total transaction of $298,815.66. Following the completion of the transaction, the vice president now directly owns 32,933 shares of the company’s stock, valued at $7,646,383.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Laura Francis sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $250.00, for a total transaction of $250,000.00. Following the transaction, the director now directly owns 3,551 shares of the company’s stock, valued at $887,750. The disclosure for this sale can be found here. Insiders sold 89,813 shares of company stock valued at $22,863,919 over the last three months. Insiders own 3.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Piper Sandler boosted their price objective on shares of Shockwave Medical from $290.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $335.00 price objective (up previously from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Wolfe Research reissued a “peer perform” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Canaccord Genuity Group reissued a “hold” rating and set a $335.00 price objective (up previously from $263.00) on shares of Shockwave Medical in a research note on Friday, April 5th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Shockwave Medical in a research note on Friday, April 5th. Ten investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $309.11.

Shockwave Medical Stock Up 0.3 %

Shares of Shockwave Medical stock opened at $330.00 on Friday. The company has a debt-to-equity ratio of 1.09, a quick ratio of 10.73 and a current ratio of 11.76. The stock has a market capitalization of $12.34 billion, a PE ratio of 85.27, a price-to-earnings-growth ratio of 2.45 and a beta of 0.92. Shockwave Medical, Inc. has a 52-week low of $157.00 and a 52-week high of $331.58. The company has a 50-day simple moving average of $294.88 and a two-hundred day simple moving average of $233.41.

Shockwave Medical (NASDAQ:SWAV) last released its quarterly earnings data on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.24. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The firm had revenue of $202.98 million during the quarter, compared to analysts’ expectations of $199.43 million. During the same period in the previous year, the company earned $3.71 earnings per share. The firm’s quarterly revenue was up 41.0% on a year-over-year basis. On average, analysts anticipate that Shockwave Medical, Inc. will post 4.94 EPS for the current fiscal year.

About Shockwave Medical

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.